Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
14M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
292K
-
Shares change
-
+217K
-
Total reported value, excl. options
-
$444K
-
Value change
-
+$327K
-
Number of buys
-
6
-
Number of sells
-
-2
-
Price
-
$1.52
Significant Holders of MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (MGRX) as of Q2 2025
11 filings reported holding MGRX - MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share as of Q2 2025.
MANGOCEUTICALS, INC. - Common Stock, $0.0001 par value per share (MGRX) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 292K shares
of 14M outstanding shares and own 2.09% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (183K shares), Ackerman Capital Advisors, LLC (34.5K shares), RENAISSANCE TECHNOLOGIES LLC (31K shares), GEODE CAPITAL MANAGEMENT, LLC (26.5K shares), GOLDMAN SACHS GROUP INC (10.6K shares), OSAIC HOLDINGS, INC. (2.89K shares), Steward Partners Investment Advisory, LLC (2.09K shares), Tower Research Capital LLC (TRC) (1.85K shares), BANK OF AMERICA CORP /DE/ (163 shares), and UBS Group AG (79 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.